This federal contract award, valued at $1,005.03, was issued by the Medical Supply Chain division of the Defense agency to The Maclean Group LLC, a self-certified small disadvantaged, veteran-owned, and service-disabled veteran-owned business. The contract is for the purchase of naloxone hydrochloride, a critical drug used to reverse opioid overdoses. The Maclean Group has an extensive history of providing a wide range of medical equipment, water treatment systems, and other products and services to various federal agencies, including the Department of Veterans Affairs, Department of Defense, Department of the Interior, and Department of Justice. The company holds several significant federal contract vehicles, including a $2.63 million Federal Supply Schedule contract with the VA for medical supplies and a $500,000 GSA Federal Supply Schedule contract covering various equipment and services. This contract award is not set-aside and has an ultimate completion date of October 30, 2024.
Generated 1/14/25, 9:10 AM